PPARG and metabolic dysfunction-associated steatohepatitis: Concurrently, THC intervention attenuated hepatic steatosis and fibrosis, mimicking the effects of the PPARG antagonist GW9662, which improves lipid metabolism in NASH mice (Xiao et al., 2023).